Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (413)

« Back to Publications

Person writing with pen

Development of a Complex Intervention to Support High Calorie Diets for People With Amyotrophic Lateral Sclerosis.

Griffiths AW. et al, (2026), Muscle Nerve, 74, 149 - 158

A qualitative exploration of how people with motor neurone disease who use tracheostomy ventilation understand and experience quality of life.

Turner N. et al, (2026), Disabil Rehabil, 1 - 12

Long-Term Exposure to Ambient Air Pollution and Incident Amyotrophic Lateral Sclerosis: A Prospective Cohort Analysis of the UK Biobank.

Chalitsios CV. et al, (2026), Neurology, 106

Effects of Age on Resting-State Cortical Networks.

Gohil C. et al, (2026), Hum Brain Mapp, 47

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles.

Chalitsios CV. et al, (2026), Ann Neurol, 99, 844 - 856

ALS motor phenotypes: a revised 'OPM' classification.

Meyer T. et al, (2026), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 13

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing.

Trubshaw M. et al, (2026), Prog Neurobiol, 257

Aquatic neurology.

Wood R. et al, (2026), Pract Neurol

Considering prediagnostic environmental modifiers of progression in amyotrophic lateral sclerosis

Chalitsios CV. and Turner MR., (2026), BMJ Neurology Open, 8, e001702 - e001702

Global & Community Health: What Did the COVID-19 Pandemic Teach Us About Neurologic Surveillance Approaches, and How Should We Be Better Prepared?

Matthews R. et al, (2025), Neurology, 105

Neurodegenerative disease in C9orf72 repeat expansion carriers: population risk and effect of UNC13A.

Gao J. et al, (2025), Brain, 148, 3865 - 3871

Design considerations for C9orf72 disease prevention trials.

Benatar M. et al, (2025), Brain, 148, 3844 - 3855

Inverting the logic in amyotrophic lateral sclerosis.

Turner MR., (2025), Brain, 148, 3783 - 3786

Toward therapeutic trials in primary lateral sclerosis.

Scirocco E. et al, (2025), Amyotroph Lateral Scler Frontotemporal Degener, 26, 623 - 630

Living with tracheostomy ventilation for motor neurone disease: a qualitative study of family member perspectives.

Wilson E. et al, (2025), Disabil Rehabil, 1 - 13

Load More

1
2
3
4
5
6
7
...
»